CIK 0001770121
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sana Biotechnology, Inc.
Sign in to watch- Ticker
- SANA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831381173
- Phone
- +1 206-701-7914
- Business address
- 188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
- 4 Shares withheld for taxes Wyrick Susan D. gave up 490 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 290,912 shares at an average $6.49 ($1,887,320)
- 4 Grant or award Director acquired 14,285 shares (grant or award)
- 4 Shares withheld for taxes Wyrick Susan D. gave up 1,566 shares (to pay taxes)
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 5,938 shares (grant or award)
- 4 Planned sale Director sold 300,000 shares at an average $3.99 ($1,195,740)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Grant or award Director acquired 4,911 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 10 · 193 filings